Immune Dynamics During Cancer Intervention: Mechanistic Insights and Translational Perspectives

The study of immune dynamics in the context of cancer interventions is a rapidly evolving field at the intersection of immunology and oncology. Cancer treatments, including surgery, radiotherapy, chemotherapy, immunotherapy, and supportive care, do much more than target malignant cells; they profoundly affect both systemic and local immune networks. Recent work demonstrates that the immune system’s response to therapeutic perturbation can critically shape disease outcomes by modifying tumor–host interactions, dictating immune surveillance capacity, and influencing tumor adaptation or resistance. Despite significant progress in understanding individual effectors and pathways, crucial questions remain about the comprehensive mechanisms through which various interventions reprogram the immune contexture within tumors and across affected tissues. Notably, variability in immune responses among patients and interventions complicates predictions of efficacy, while the increasing implementation of multi-omics and advanced profiling tools has begun to unravel the layered complexity of these responses. However, the translation of these detailed mechanistic insights into actionable clinical strategies remains an ongoing challenge, underscoring the need for deeper interrogation of immune modulation as a driver of cancer therapy outcomes.This Research Topic aims to bring together basic and translational research exploring how diverse cancer treatment modalities alter immune regulation at the molecular, cellular, and tissue landscape levels. We seek to highlight investigations that define precise mechanisms mediating innate and adaptive immune responses, transformations within the tumor microenvironment, and the interplay of inflammatory and metabolic pathways following therapeutic intervention. By encouraging the integration of experimental models, high-dimensional immune profiling, advanced imaging, and multi-omics analyses, this Research Topic strives to construct a holistic and mechanistically grounded framework that recognizes intervention-induced immune modulation as a pivotal determinant of therapeutic success. The ultimate objective is to foster an evidence base that can inform the design of immune-aware and rational multi-modal cancer therapies.The Research Topic is focused on the mechanistic and translational aspects of immune responses to cancer interventions, encompassing molecular, cellular, and tissue-level changes while excluding articles centered solely on clinical outcomes without mechanistic context. We encourage contributions using innovative tools and approaches that directly unravel immune dynamics in response to treatment.To gather further insights in this domain, we welcome articles addressing, but not limited to, the following themes:- Mechanistic dissection of innate and adaptive immune responses post-intervention- Remodeling of the tumor microenvironment during and after therapy- Inflammatory and immunometabolic signaling in response to cancer treatments- Application of high-dimensional immune profiling and multi-omics for immune monitoring- Immune-mediated mechanisms of tumor progression, dormancy, or resistance after intervention- Integration of experimental models and clinical samples for translational advances- Strategies for harnessing or modulating post-therapy immune responses to optimize outcomesPlease note: manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent clinical or patient cohort, or biological validation in vitro or in vivo, which are not based on public databases) are not suitable for publication in this Research Topic. Topic editors: Rosalba Florio, Nehad Ahmed, Davide Brocco, Marwa Balaha, Mohamed Balaha Source: https://www.frontiersin.org/research-topics/81272/immune-dynamics-during-cancer-intervention-mechanistic-insights-and-translational-perspectives